Timothy F. Howe

Tim is a graduate of Columbia College and the Columbia Graduate School of Business.

Tim has been investing in private equity since joining Schroder Ventures in 1984. He has been an active investor and board member responsible for numerous venture investments in the biotechnology, medical device and healthcare services areas, including Innotech, Inc. (acquired by Johnson & Johnson), Camitro Corporation (acquired by ArQule, Inc.), and Alexion Pharmaceuticals, Inc.

Tim also played a leading role in the formation of Biotechnology Investment Group, L.L.C., which took over a portfolio of equity investments in many financially distressed biotechnology companies. Tim was instrumental in working with these portfolio companies in arranging financings, mergers, and ultimate successful realizations.

Tim has been a director of nineteen companies and is currently on the boards of Bionaut Pharmaceuticals, Inc., Comprehensive NeuroScience, Inc., Medicus Insurance Holdings, Inc. and MedMark Services, Inc. He is also an Adjunct Assistant Professor at Columbia Graduate School of Business teaching venture capital management.

Tim can be reached at thowe@chlmedical.com.